In melanoma, this exhaustion phenotype is enriched in tumour-reactive CD4+ and CD8+ αβ T cells which demonstrate increased expression of checkpoints including PD-1, CTLA-4, TIGIT, LAG3, TIM3, and CD39 [29–31]. This evidence concerns the gene CTLA4 and melanoma.